Osphena® (ospemifene) is the first and only FDA-approved, once-daily, oral, non-hormonal treatment to treat both moderate to severe vaginal dryness and/or painful intercourse, symptoms of changes in and around your vagina due to menopause. See Importa
基本信息 Ospemifene(奥培米芬)由盐野义(Shionogi)研发,于2013年2月26日首次获美国食品药品管理局(FDA)批准上市,后又于2015年1月15日获欧洲药物管理局(EMA)批准上市,由盐野义在美国和欧洲上市销售,商品名分别为Osphena®和Senshio®。 奥培米芬是一种有组织选...
Osphena:奥培米芬片 奥培米芬(Ospemifene)是托瑞米芬的活性代谢产物之一,也是新型选择性雌激素受体调节剂,既具有雌激素作用,也具有抗雌激素作用,表现为组织选择性,FDA批准该药用于治疗更年期女性性交疼痛。更年期女性由于雌激素水平下降,导致阴道萎缩干燥,引起性交疼痛,奥培米芬的雌激素作用能缓解这些症状。三项随机双...
Osphena再度获批用于治疗女性中重度阴道干燥 Osphena(aspemifene)是由一家专门从事女性健康的制药公司Duchesnay研发的药物。该药在近日被美国FDA批准了补充的新药申请(sNDA),用于治疗女性中度至重度阴道干燥的症状。Osphena在早前也已获批用于治疗中度至重度性交困难(性交疼痛),这也是由绝经所致VVA的一种症状。 阴道干燥...
奥培米芬片 OSPHENA (ospemifene) FDA药品说明书翻译 FULL PRESCRIBING INFORMATION WARNING: ENDOMETRIAL CANCER AND CARDIOVASCULAR DISORDERS 警告：子宫内膜癌和心血管疾病 Endometrial Cancer 子宫内膜癌 OSPHENA is an estrogen agonist/antagonist with tissue selective effects. In the endometrium, OSPHENA has ...
The article presents information on ospemifene tablet or Osphena, a selective receptor modulator, also known as an estrogen/antagonist. The drug was approved by the U.S. Food and Drug Administration (FDA) for the treatment of dyspareunia in postmenopausal women. The potential advantages and ...
【药品名称】 奥培米芬 ospemifene Osphena 【规格】 60mg/30片 【适应症】 奥培米芬是一种雌激素激动剂/拮抗剂,主要在于治疗妇女因更年期引起的外阴和阴道萎缩,以及由此导致的中度至重度的性交疼痛(VVA)。 【用法用量】 每天1次与食物口服1片。 【生产企业】 日本盐野义 为...
Osphena Ther. Class. hormones Pharm. Class. estrogen agonists/antagonists Indications Indications Indications Moderate to severe dyspareunia due to menopausal vulvar/vaginal atrophy. Moderate to severe vaginal dryness due to menopausal vulvar/vaginal atrophy. ...
Osphena Ther. Class. hormones Pharm. Class. estrogen agonists/antagonists Indications Indications Indications Moderate to severe dyspareunia due to menopausal vulvar/vaginal atrophy. Moderate to severe vaginal dryness due to menopausal vulvar/vaginal atrophy. ...
奥培米芬片_OSPHENA_(ospemifene)_FDA药品说明书翻译